Filing Details
- Accession Number:
- 0000904454-21-000676
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-09-22 09:24:53
- Reporting Period:
- 2021-09-21
- Accepted Time:
- 2021-09-22 09:24:53
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1590560 | Uniqure N.v. | QURE | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1711885 | Christian Klemt | C/O Uniqure N.v. Paasheuvelweg 25A Amsterdam P7 11058BP | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Disposition | 2021-09-21 | 2,400 | $38.00 | 70,783 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b-5 under the Securities Exchange Act of 1934.
Billionaire Hedge Funds
